Filing Flows › AstraZeneca (AZN) › Q2 2026 › vs Q1 2026
AstraZeneca (AZN) Q2 2026 vs Q1 2026 (quarter over quarter)
AstraZeneca's revenue rose $15.4B (+101%) from $15.3B in Q1 2026 to $30.7B in Q2 2026. Gross margin 83.0% against 82.5% (+0.6 pts).
AstraZeneca, Q2 2026: revenue $30.7B (+9% year over year), operating margin 24.2%, net earnings $5.6B. The chart draws each line against Q1 2026, the increases inside each band.
Margins
| Q2 2026 | Q1 2026 | Change | |
|---|---|---|---|
| Gross margin | 83.0% | 82.5% | +0.6 pts |
| Operating margin | 24.2% | 27.8% | -3.6 pts |
| Net margin | 18.2% | 20.2% | -1.9 pts |
Every line
| Line | Q2 2026 | Q1 2026 | Change | % |
|---|---|---|---|---|
| Revenue | $30.7B | $15.3B | $15.4B | +101% |
| Gross profit | $25.5B | $12.6B | $12.9B | +102% |
| Cost of revenue | $5.2B | $2.7B | $2.5B | +94% |
| Operating profit | $7.4B | $4.2B | $3.2B | +75% |
| Operating expenses | $18.1B | $8.4B | $9.7B | +116% |
| Pre-tax earnings | $6.7B | $3.9B | $2.8B | +72% |
| Other expense, net | $697M | $332M | $365M | +110% |
| Net earnings | $5.6B | $3.1B | $2.5B | +81% |
| Income tax | $1.1B | $833M | $291M | +35% |
Questions
How much did AstraZeneca's revenue grow quarter over quarter in Q2 2026?
AstraZeneca's revenue rose $15.4B (+101%) from $15.3B in Q1 2026 to $30.7B in Q2 2026. Gross margin 83.0% against 82.5% (+0.6 pts).